Ávalos-Moreno, M.; López-Tejada, A.; Blaya-Cánovas, J.L.; Cara-Lupiañez, F.E.; González-González, A.; Lorente, J.A.; Sánchez-Rovira, P.; Granados-Principal, S.
Drug Repurposing for Triple-Negative Breast Cancer. J. Pers. Med. 2020, 10, 200.
https://doi.org/10.3390/jpm10040200
AMA Style
Ávalos-Moreno M, López-Tejada A, Blaya-Cánovas JL, Cara-Lupiañez FE, González-González A, Lorente JA, Sánchez-Rovira P, Granados-Principal S.
Drug Repurposing for Triple-Negative Breast Cancer. Journal of Personalized Medicine. 2020; 10(4):200.
https://doi.org/10.3390/jpm10040200
Chicago/Turabian Style
Ávalos-Moreno, Marta, Araceli López-Tejada, Jose L. Blaya-Cánovas, Francisca E. Cara-Lupiañez, Adrián González-González, Jose A. Lorente, Pedro Sánchez-Rovira, and Sergio Granados-Principal.
2020. "Drug Repurposing for Triple-Negative Breast Cancer" Journal of Personalized Medicine 10, no. 4: 200.
https://doi.org/10.3390/jpm10040200
APA Style
Ávalos-Moreno, M., López-Tejada, A., Blaya-Cánovas, J. L., Cara-Lupiañez, F. E., González-González, A., Lorente, J. A., Sánchez-Rovira, P., & Granados-Principal, S.
(2020). Drug Repurposing for Triple-Negative Breast Cancer. Journal of Personalized Medicine, 10(4), 200.
https://doi.org/10.3390/jpm10040200
